{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:23:47Z","timestamp":1793838227759,"version":"4.6.1"},"reference-count":178,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.cytogfr.2010.10.011","type":"journal-article","created":{"date-parts":[[2010,11,27]],"date-time":"2010-11-27T04:48:41Z","timestamp":1290833321000},"page":"1-18","source":"Crossref","is-referenced-by-count":168,"title":["The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Jo","family":"Vandercappellen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2010.10.011_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.3.1.110","article-title":"Differentiation of certain platelet factors related to blood coagulation","volume":"3","author":"Deutsch","year":"1955","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0010","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1073\/pnas.74.6.2256","article-title":"Amino acid sequence of human platelet factor 4","volume":"74","author":"Deuel","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0015","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1016\/S0021-9258(17)39951-9","article-title":"Isolation, crystallization, and primary amino acid sequence of human platelet factor 4","volume":"252","author":"Hermodson","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0020","first-page":"53","article-title":"Studies on the chemistry of human platelet factor 4","volume":"6","author":"Morgan","year":"1977","journal-title":"Haemostasis"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0049-3848(77)90117-7","article-title":"Primary structure of human platelet factor 4","volume":"11","author":"Walz","year":"1977","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V69.1.219.219","article-title":"Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line","volume":"69","author":"Poncz","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/MCB.7.2.898","article-title":"Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation","volume":"7","author":"Doi","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0040","doi-asserted-by":"crossref","first-page":"12365","DOI":"10.1016\/S0021-9258(19)86324-X","article-title":"Purification of a heparin-neutralizing protein from rabbit platelets and its homology with human platelet Factor 4","volume":"254","author":"Ginsberg","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0003-9861(86)90723-X","article-title":"Isolation and amino acid sequence of bovine platelet factor 4","volume":"250","author":"Ciaglowski","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0050","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V61.6.1072.1072","article-title":"Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins","volume":"61","author":"Rucinski","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0055","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0049-3848(91)90351-V","article-title":"Ovine platelet factor 4: purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species","volume":"64","author":"Shigeta","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/MCB.9.4.1445","article-title":"Identification and characterization of PF4varl, a human gene variant of platelet factor 4","volume":"9","author":"Green","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood.V76.2.336.336","article-title":"Structural and functional comparison of the genes for human platelet factor 4 and PF4alt","volume":"76","author":"Eisman","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cytogfr.2010.03.004","article-title":"The evolution of mammalian chemokine genes","volume":"21","author":"Nomiyama","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0075","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood.V79.11.2896.bloodjournal79112896","article-title":"Genes for beta-thromboglobulin and platelet factor 4 are closely linked and form part of a cluster of related genes on chromosome 4","volume":"79","author":"Tunnacliffe","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0080","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1021\/bi00193a025","article-title":"Crystal structure of recombinant human platelet factor 4","volume":"33","author":"Zhang","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0085","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1021\/bi00450a034","article-title":"Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy","volume":"28","author":"Mayo","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.RES.0000146674.38319.07","article-title":"Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4\/CXCL4 and potent inhibitor of angiogenesis","volume":"95","author":"Struyf","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0095","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1182\/blood-2006-10-052035","article-title":"PF-4\/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion","volume":"109","author":"Lasagni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1084\/jem.154.1.88","article-title":"Human megakaryocytes II. Expression of platelet proteins in early marrow megakaryocytes","volume":"154","author":"Rabellino","year":"1981","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0105","doi-asserted-by":"crossref","first-page":"30329","DOI":"10.1074\/jbc.M503847200","article-title":"Evidence for a granule targeting sequence within platelet factor 4","volume":"280","author":"El Golli","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood.V53.4.604.604","article-title":"Platelet alpha-granule proteins: studies on release and subcellular localization","volume":"53","author":"Kaplan","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/2221269a0","article-title":"Platelet factor 4 and adenosine diphosphate release during human platelet aggregation","volume":"222","author":"Niewiarowski","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0120","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00018-010-0306-x","article-title":"Platelet-derived chemokines: pathophysiology and therapeutic aspects","volume":"67","author":"Flad","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.20051772","article-title":"Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo","volume":"203","author":"Massberg","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/713773647","article-title":"Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense","volume":"10","author":"Gear","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0135","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.98.12.1164","article-title":"Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells","volume":"98","author":"Gawaz","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V58.3.607.607","article-title":"Studies of human plate alpha-granule release in vivo","volume":"58","author":"Files","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3181\/00379727-198-43309","article-title":"Platelet factor 4: production, structure, and physiologic and immunologic action","volume":"198","author":"Zucker","year":"1991","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0049-3848(80)90431-4","article-title":"Human platelet factor 4 and tissue mast cells","volume":"19","author":"McLaren","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1189\/jlb.0105024","article-title":"Regulated expression of platelet factor 4 in human monocytes-role of PARs as a quantitatively important monocyte activation pathway","volume":"78","author":"Schaffner","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0160","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1189\/jlb.0407206","article-title":"Stimulation of angiostatic platelet factor-4 variant (CXCL4L1\/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6\/GCP-2) in normal and tumoral mesenchymal cells","volume":"82","author":"Vandercappellen","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0165","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1471-4159.2008.05267.x","article-title":"Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3","volume":"105","author":"de Jong","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0170","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.humpath.2009.09.021","article-title":"Expression of angiostatic platelet factor-4var\/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8\/CXCL8, and stromal cell-derived factor 1\/CXCL12 in esophageal and colorectal cancer","volume":"41","author":"Verbeke","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0175","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/S0021-9258(17)33292-1","article-title":"Purification and binding properties of human platelet factor four","volume":"251","author":"Handin","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0021-9258(17)33882-6","article-title":"Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4","volume":"251","author":"Levine","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1432-1033.1989.tb14729.x","article-title":"Purification of granulocyte chemotactic peptide\/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin","volume":"181","author":"Van Damme","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0190","doi-asserted-by":"crossref","first-page":"20508","DOI":"10.1074\/jbc.272.33.20508","article-title":"Specific binding of the chemokine platelet factor 4 to heparan sulfate","volume":"272","author":"Stringer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0195","doi-asserted-by":"crossref","first-page":"12376","DOI":"10.1074\/jbc.274.18.12376","article-title":"Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4","volume":"274","author":"Petersen","year":"1999","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"10.1016\/j.cytogfr.2010.10.011_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/bj3120357","article-title":"Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding","volume":"312","author":"Mayo","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0205","doi-asserted-by":"crossref","unstructured":"Struyf S, Salogni L, Burdick MD, Vandercappellen J, Gouwy M, Noppen S, et al. The angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. Blood, in press, doi:10.1182\/blood-2009-11-253591.","DOI":"10.1182\/blood-2009-11-253591"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0210","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10 Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI9775","article-title":"Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity","volume":"107","author":"Romagnani","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0220","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.biocel.2008.01.008","article-title":"Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B","volume":"40","author":"Petrai","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0225","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1189\/jlb.1006645","article-title":"CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3","volume":"83","author":"Mueller","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0230","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.200324235","article-title":"Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation","volume":"33","author":"Xanthou","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0235","doi-asserted-by":"crossref","first-page":"30219","DOI":"10.1074\/jbc.M403595200","article-title":"Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function","volume":"279","author":"Colvin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0240","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2004-01-0214","article-title":"Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11","volume":"107","author":"Dagan-Berger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0245","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.173.10.6234","article-title":"Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping","volume":"173","author":"Ehlert","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0250","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V56.4.596.596","article-title":"In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta)","volume":"56","author":"Musial","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0255","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.V61.6.1208.1208","article-title":"Effect of heparin on the in vivo release and clearance of human platelet factor 4","volume":"61","author":"Rao","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0260","first-page":"H800","article-title":"Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin","volume":"251","author":"Rucinski","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0049-3848(82)90279-1","article-title":"The in vivo release of human platelet factor 4 by heparin","volume":"27","author":"Dawes","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0270","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood.V73.6.1534.1534","article-title":"Interaction of platelet factor four with cultured vascular endothelial cells","volume":"73","author":"Rybak","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0049-3848(80)90412-0","article-title":"Binding of platelet factor 4 to cultured human umbilical vein endothelial cells","volume":"19","author":"Busch","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0280","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","article-title":"Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact","volume":"96","author":"Van den Steen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0285","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.181.4.1311","article-title":"The Duffy antigen\/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor","volume":"181","author":"Peiper","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0290","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cytogfr.2005.05.003","article-title":"Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines","volume":"16","author":"Locati","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0295","first-page":"650","article-title":"Normal human serum contains a factor(s) capable of inhibiting megakaryocyte colony formation","volume":"10","author":"Vainchenker","year":"1982","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0300","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V75.6.1234.1234","article-title":"Platelet factor 4 inhibits human megakaryocytopoiesis in vitro","volume":"75","author":"Han","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0305","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.V86.7.2559.2559","article-title":"Chemokine regulation of human megakaryocytopoiesis","volume":"86","author":"Gewirtz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0310","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1182\/blood.V91.8.2772.2772_2772_2780","article-title":"New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides","volume":"91","author":"Lecomte-Raclet","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0315","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.4049\/jimmunol.150.8.3448","article-title":"Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression","volume":"150","author":"Broxmeyer","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0320","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1182\/blood-2007-01-067116","article-title":"Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications","volume":"110","author":"Lambert","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0325","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1182\/blood-2002-08-2363","article-title":"Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis","volume":"101","author":"Dudek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0330","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1074\/jbc.M405364200","article-title":"Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level","volume":"280","author":"Nesmelova","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0335","doi-asserted-by":"crossref","first-page":"23282","DOI":"10.1074\/jbc.270.40.23282","article-title":"High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4","volume":"270","author":"Daly","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3181\/00379727-69-16693","article-title":"The relationship of heparin activity to platelet concentration","volume":"69","author":"Conley","year":"1948","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0345","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1016\/S0021-9258(19)43472-8","article-title":"The purification and mechanism of action of human antithrombin-heparin cofactor","volume":"248","author":"Rosenberg","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0350","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/bj1960649","article-title":"Dansyl (5-dimethylaminonaphthalene-1-sulphonyl)-heparin binds antithrombin III and platelet factor 4 at separate sites","volume":"196","author":"Piepkorn","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0355","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/01.CIR.91.8.2188","article-title":"Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans","volume":"91","author":"Dehmer","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0049-3848(80)90284-4","article-title":"Inhibition of contact activation by platelet factor 4","volume":"20","author":"Scully","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0365","first-page":"394","article-title":"Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4","volume":"112","author":"Dumenco","year":"1988","journal-title":"J Lab Clin Med"},{"issue":"Suppl 1","key":"10.1016\/j.cytogfr.2010.10.011_bib0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1538-7836.2007.02491.x","article-title":"Activated protein C","volume":"5","author":"Griffin","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0375","doi-asserted-by":"crossref","first-page":"25549","DOI":"10.1016\/S0021-9258(18)47284-5","article-title":"Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis","volume":"269","author":"Slungaard","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0380","doi-asserted-by":"crossref","first-page":"31785","DOI":"10.1074\/jbc.272.50.31785","article-title":"Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C","volume":"272","author":"Dudek","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0385","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2003-11-3994","article-title":"Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin","volume":"104","author":"Eslin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0390","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.6994228","article-title":"Vascular permeation of platelet factor 4 after endothelial injury","volume":"209","author":"Goldberg","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0395","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.156.5.1954","article-title":"TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines","volume":"156","author":"Petersen","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0400","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.170.5.1745","article-title":"Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils","volume":"170","author":"Walz","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0405","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jlb.39.4.423","article-title":"In vitro effects of platelet factor 4 on normal human neutrophil functions","volume":"39","author":"Bebawy","year":"1986","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0410","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.4049\/jimmunol.161.8.4347","article-title":"A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation","volume":"161","author":"Petersen","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0415","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood-2003-08-2802","article-title":"Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase","volume":"103","author":"Kasper","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0420","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2005-06-2501","article-title":"Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras Syk, and JNK MAP kinases","volume":"107","author":"Kasper","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0425","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1182\/blood.V94.12.4020","article-title":"Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8","volume":"94","author":"Petersen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0430","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1182\/blood-2005-06-2424","article-title":"Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G","volume":"107","author":"Schiemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0435","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI110099","article-title":"Stimulation of human leukocyte elastase by platelet factor 4. Physiologic, morphologic, and biochemical effects on hamster lungs in vitro","volume":"67","author":"Lonky","year":"1981","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.cytogfr.2010.10.011_bib0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000236754","article-title":"Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion","volume":"104","author":"Hayashi","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0445","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI111077","article-title":"Stimulation of histamine release from human basophils by human platelet factor 4","volume":"72","author":"Brindley","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0450","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.4049\/jimmunol.0803587","article-title":"The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4","volume":"183","author":"Schiemann","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0455","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.molimm.2010.05.005","article-title":"Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells","volume":"47","author":"Willox","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0460","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0465","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1096\/fj.03-1435fje","article-title":"Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells","volume":"18","author":"Fricke","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0470","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/intimm\/dxg100","article-title":"Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells","volume":"15","author":"Xia","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0475","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.4049\/jimmunol.0901368","article-title":"CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages","volume":"184","author":"Gleissner","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0480","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.173.3.2060","article-title":"Platelet factor 4\/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients","volume":"173","author":"Pervushina","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0485","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.4049\/jimmunol.179.4.2584","article-title":"Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways","volume":"179","author":"Kasper","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0490","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/eji.200939703","article-title":"CXCL4-induced monocyte survival, cytokine expression, and oxygen radical formation is regulated by sphingosine kinase 1","volume":"40","author":"Kasper","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0495","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1189\/jlb.0907592","article-title":"Platelet factor 4\/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals","volume":"83","author":"Woller","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0500","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","article-title":"Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium","volume":"105","author":"von Hundelshausen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0505","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1189\/jlb.72.3.590","article-title":"Platelet factor 4 induces human natural killer cells to synthesize and release interleukin-8","volume":"72","author":"Marti","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0510","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1073\/pnas.83.10.3491","article-title":"Protease-induced immunoregulatory activity of platelet factor 4","volume":"83","author":"Katz","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0515","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1073\/pnas.86.19.7571","article-title":"Immunoregulatory activity of peptides related to platelet factor 4","volume":"86","author":"Zucker","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0520","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4049\/jimmunol.169.2.770","article-title":"Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells","volume":"169","author":"Fleischer","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0525","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaci.2005.09.035","article-title":"CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production","volume":"116","author":"Romagnani","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0530","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.4049\/jimmunol.174.5.2680","article-title":"Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25\u2212 (non-regulatory) T cells","volume":"174","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0535","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1688470","article-title":"Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides","volume":"247","author":"Maione","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0540","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jnci\/82.10.848","article-title":"Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4","volume":"82","author":"Sharpe","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0545","first-page":"2077","article-title":"Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity","volume":"51","author":"Maione","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0550","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jnci\/87.4.304","article-title":"Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4","volume":"87","author":"Kolber","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0555","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nm0497-437","article-title":"Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth","volume":"3","author":"Tanaka","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0560","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1083\/jcb.127.4.1121","article-title":"Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression","volume":"127","author":"Gupta","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0565","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI117316","article-title":"Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor","volume":"94","author":"Watson","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0570","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1074\/jbc.270.25.15059","article-title":"Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms","volume":"270","author":"Gengrinovitch","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0575","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.182.1.219","article-title":"The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation","volume":"182","author":"Luster","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0580","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V91.9.3289","article-title":"Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization","volume":"91","author":"Perollet","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0585","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood.V94.3.984.415k31_984_993","article-title":"Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action","volume":"94","author":"Jouan","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0590","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood.V100.9.3087","article-title":"Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway","volume":"100","author":"Sulpice","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0595","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V93.1.25","article-title":"Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1\/WAF1)","volume":"93","author":"Gentilini","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0600","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.92.17.7799","article-title":"A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4","volume":"92","author":"Gupta","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0605","doi-asserted-by":"crossref","first-page":"35723","DOI":"10.1074\/jbc.M101565200","article-title":"Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity","volume":"276","author":"Lozano","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0610","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1158\/1078-0432.CCR-04-0194","article-title":"Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma","volume":"10","author":"Bello","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0615","first-page":"2499","article-title":"Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo","volume":"63","author":"Giussani","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0620","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1096\/fj.00-0285fje","article-title":"A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2","volume":"15","author":"Hagedorn","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0625","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","article-title":"Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model","volume":"279","author":"Arap","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0630","first-page":"6884","article-title":"Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors","volume":"62","author":"Hagedorn","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0635","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/0264-6021:3540233","article-title":"Anginex, a designed peptide that inhibits angiogenesis","volume":"354","author":"Griffioen","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0640","doi-asserted-by":"crossref","unstructured":"Dubrac A, Quemener C, Lacazette E, Lopez F, Zanibellato C, Wu WG, et al. Functional divergence between two chemokines is conferred by single amino acid change. Blood, in press, doi:10.1182\/blood-2010-03-274852.","DOI":"10.1182\/blood-2010-03-274852"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0645","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1158\/0008-5472.CAN-06-4682","article-title":"Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis","volume":"67","author":"Struyf","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0650","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/1541-7786.MCR-09-0176","article-title":"The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1\/PF-4var47\u201370) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo","volume":"8","author":"Vandercappellen","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0655","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood.V59.1.96.96","article-title":"Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance","volume":"59","author":"Arthur","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0660","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000132431","article-title":"Human platelet factor 4 gene is mapped to 4q12-q21","volume":"45","author":"Griffin","year":"1987","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0665","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2006-04-018770","article-title":"4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4","volume":"109","author":"Cheng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0670","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1073\/pnas.0610330104","article-title":"Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease","volume":"104","author":"Aivado","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0675","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2007-04-084798","article-title":"Platelet-associated PF-4 as a biomarker of early tumor growth","volume":"111","author":"Cervi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0680","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(98)05095-8","article-title":"Involvement of platelets in tumour angiogenesis?","volume":"352","author":"Pinedo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0685","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1158\/1078-0432.CCR-08-2701","article-title":"Serum peptidome profiling revealed platelet factor 4 as a potential discriminating peptide associated with pancreatic cancer","volume":"15","author":"Fiedler","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0690","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/pmic.200401165","article-title":"Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer","volume":"5","author":"Lam","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0695","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10585-010-9311-6","article-title":"Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer","volume":"27","author":"Wiesner","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0700","first-page":"4035","article-title":"Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma","volume":"18","author":"Borgstrom","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0705","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00180815","article-title":"Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma","volume":"14","author":"Belman","year":"1996","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0710","first-page":"288","article-title":"Phase I\/II study of intravenous recombinant platelet factor-4 in AIDS-related Kaposi's sarcoma","volume":"14","author":"Northfelt","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0715","first-page":"50","article-title":"A randomized dose finding study of recombinant platelet factor-4 in cutaneous AIDS-related Kaposi's sarcoma","volume":"13","author":"Staddon","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0720","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Huo","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0725","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0730","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1182\/blood-2004-07-2617","article-title":"Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0735","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V99.10.3613","article-title":"Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface","volume":"99","author":"Sachais","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0740","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1074\/jbc.M208894200","article-title":"Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells","volume":"278","author":"Nassar","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0745","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH03-02-0069","article-title":"Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters","volume":"90","author":"Pitsilos","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0750","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCRESAHA.109.199505","article-title":"CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages","volume":"106","author":"Gleissner","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0755","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1160\/TH07-04-0271","article-title":"Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl\/6 and apoE\u2212\/\u2212 mice","volume":"98","author":"Sachais","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0760","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm.1898","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0765","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<196::AID-AJH4>3.0.CO;2-R","article-title":"Characterization of the humoral immune response in heparin-induced thrombocytopenia","volume":"54","author":"Suh","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0770","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0775","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1365-2141.1996.407945.x","article-title":"Pathogenicity of IgA and\/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia","volume":"92","author":"Amiral","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0780","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0785","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0790","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0795","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2141.1996.d01-1876.x","article-title":"The epitope specificity of heparin-induced thrombocytopenia","volume":"95","author":"Horsewood","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0800","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","article-title":"Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4","volume":"83","author":"Kelton","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0805","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1182\/blood.V92.9.3250","article-title":"Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia","volume":"92","author":"Ziporen","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0810","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0815","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0820","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V96.1.182","article-title":"Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation","volume":"96","author":"Newman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0825","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0830","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2362.2000.00616.x","article-title":"Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis","volume":"30","author":"Vrij","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0835","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bcp.2006.12.019","article-title":"Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling","volume":"73","author":"Meuwis","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0840","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.clinbiochem.2008.04.021","article-title":"Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study","volume":"41","author":"Meuwis","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0845","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/ard.2008.093153","article-title":"Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis","volume":"68","author":"Trocme","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0850","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nri1686","article-title":"Immunological processes in malaria pathogenesis","volume":"5","author":"Schofield","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0855","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.chom.2008.07.003","article-title":"Platelet factor 4 mediates inflammation in experimental cerebral malaria","volume":"4","author":"Srivastava","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0860","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1073\/pnas.0801544105","article-title":"Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria","volume":"105","author":"Campanella","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0865","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/eji.200737906","article-title":"CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines","volume":"38","author":"Van den Steen","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0870","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.167.2.623","article-title":"Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity","volume":"167","author":"Cole","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0875","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbamem.2006.11.010","article-title":"Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins","volume":"1768","author":"Yeaman","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0880","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI115880","article-title":"Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity","volume":"90","author":"Darveau","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0885","doi-asserted-by":"crossref","first-page":"24155","DOI":"10.1074\/jbc.M803308200","article-title":"CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations","volume":"283","author":"Nesmelova","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2010.10.011_bib0890","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1753425909106171","article-title":"Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication","volume":"15","author":"Schwartzkopff","year":"2009","journal-title":"Innate Immun"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961011000078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961011000078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:04:36Z","timestamp":1685855076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135961011000078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":178,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S135961011000078X"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2010.10.011","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}